Hasumi K, Shinohara C, Naganuma S, Endo A
Department of Applied Biological Science, Tokyo Noko University, Fuchu-shi, Japan.
Eur J Biochem. 1992 Apr 15;205(2):841-6. doi: 10.1111/j.1432-1033.1992.tb16848.x.
The antiprotozoal antibiotic ikarugamycin was found to significantly inhibit oxidized low-density lipoprotein(LDL)-induced accumulation of cholesteryl ester in macrophage J774 at a concentration over 1-4 microM. Cholesteryl ester synthesis from [14C]oleate in the macrophages was similarly inhibited by the antibiotic, while the synthesis of triacylglycerol and polar lipids was not affected. The internalization of oxidized [125I]LDL in macrophages was reduced to 50% by 2 microM ikarugamycin, while cell-surface binding of oxidized [125I]LDL, lysosomal hydrolysis of the internalized oxidized [125I]LDL and microsomal acyl-coenzyme A:cholesterol acyltransferase was not detectably inhibited by 5 microM ikarugamycin. The results demonstrated that ikarugamycin inhibited cholesteryl ester accumulation in macrophage J774 by specifically inhibiting the uptake of oxidized LDL.
抗寄生虫抗生素ikarugamycin被发现,在浓度超过1 - 4微摩尔时,能显著抑制氧化型低密度脂蛋白(LDL)诱导的巨噬细胞J774中胆固醇酯的积累。该抗生素同样抑制了巨噬细胞中由[14C]油酸合成胆固醇酯,而三酰甘油和极性脂质的合成未受影响。2微摩尔的ikarugamycin使巨噬细胞中氧化型[125I]LDL的内化减少至50%,而5微摩尔的ikarugamycin未检测到对氧化型[125I]LDL的细胞表面结合、内化的氧化型[125I]LDL的溶酶体水解以及微粒体酰基辅酶A:胆固醇酰基转移酶的抑制作用。结果表明,ikarugamycin通过特异性抑制氧化型LDL的摄取来抑制巨噬细胞J774中胆固醇酯的积累。